Yes, the levonorgestrel-releasing intrauterine system (LNG-IUD) is a progestin-only contraceptive.
The LNG-IUD releases only levonorgestrel, a synthetic progestin, without any estrogen component, making it definitively a progestin-only contraceptive method. 1, 2, 3
Mechanism and Classification
The LNG-IUD works through local progestin delivery directly to the endometrium, achieving:
- Local endometrial suppression - causing endometrial thinning, glandular atrophy, and stromal decidualization
- Cervical mucus thickening - creating a barrier to sperm penetration
- Prevention of fertilization - primarily by inhibiting sperm motility, not by preventing implantation 4, 5
Importantly, the LNG-IUD does not suppress ovulation in most users, unlike combined hormonal contraceptives. This distinguishes it from estrogen-containing methods while confirming its progestin-only classification 5.
Systemic Hormone Levels
The locally released levonorgestrel creates:
- Endometrial concentrations 200-800 times higher than oral progestin use
- Plasma levels lower than other levonorgestrel-containing contraceptives 5
This localized delivery explains why the LNG-IUD is recommended over combined estrogen-progestin contraceptives in specific high-risk populations where estrogen is contraindicated 6.
Clinical Implications of Progestin-Only Status
Because the LNG-IUD contains only progestin, it is:
- Strongly recommended for women with antiphospholipid antibodies (where estrogen is absolutely contraindicated due to thrombosis risk) 6
- Preferred for SLE patients with moderate/severe disease activity over combined hormonal methods 6
- Safe for breastfeeding women without concerns about estrogen effects on lactation 3
- Appropriate for women with estrogen contraindications including history of VTE, migraine with aura, or cardiovascular disease 1
The progestin-only nature means VTE risk is not increased (RR 0.61,95% CI 0.24-1.53) compared to the elevated risk with estrogen-containing contraceptives 6, 7.
Available Formulations
Multiple LNG-IUD products exist in the U.S., all containing only levonorgestrel:
- 52 mg levonorgestrel (Mirena, Liletta) - approved for 5 years, effective up to 7 years
- 13.5 mg levonorgestrel (Skyla) - approved for 3 years 2, 3
All are progestin-only devices without estrogen.